The relationship between shaved margin and inked margin status in breast excision specimens

Cancer

Volumn 79, Issue 8, 1997, Pages 1568-1573

  Guidi, Anthony J ^a   Connolly, James L ^a   Harris, Jay R ^a   Schnitt, Stuart J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

breast carcinoma; breast conservation; ductal carcinoma in situ; margins

Indexed keywords

INK;

ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBEDDING; EXCISION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REOPERATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARBON; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COLORING AGENTS; FEMALE; HUMANS; MICROTOMY; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES;

EID: 0030960736     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1568::AID-CNCR19>3.0.CO;2-W     Document Type: Article

References (18)

1. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
2. Hetelekidis S, Schnitt SJ, Morrow M, Harris JR. Management of ductal carcinoma in situ. CA Cancer J Clin 1995;45:244-53.
3. Clarke DH, Martinez AA. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiation therapy: a review article for surgeons, pathologists, and radiation and medical oncologists. J Clin Oncol 1992;10:474-83.
4. Schnitt SJ. Pathologic factors predictive of local recurrence in patients with invasive breast cancer treated by conservative surgery and radiation therapy. In: Fletcher GH, Levitt SH, editors. Non-disseminated breast cancer: controversial issues in management. Berlin: Springer-Verlag, 1993:93-104.
5. Kurtz JM. Factors influencing the risk of local recurrence in the breast. Ear J Cancer 1992;28:660-6.
6. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-9.
7. Lagios MD. Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment. Breast J 1995;1:68-78.
8. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986;57:1717-24.
9. Carter D. Margins of "lumpectomy" for breast cancer. Hum Pathol 1986;17:330-2.
10. Schnitt SJ, Connolly JL. Processing and evaluation of breast excision specimens: a clinically-oriented approach. Am J Clin Pathol 1992;98:125-37.
11. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991;21:279-87.
12. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Barbelink H. Risk factors in breast conservation therapy. J Clin Oncol 1994;12:653-60.
13. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990;65:1867-78.
14. Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, et al. Local failure and margin status in earlystage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993;218:22-8.
15. Spivack B, Khanna MM, Tafra L, Juillard G, Giuliano AE. Margin status and local recurrence after breast-conserving surgery. Arch Surg 1994;129:952-57.
16. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, et al. The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer 1995;76:259-67.
17. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746-51.
18. Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SM, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy Cancer 1996;78:1921-8.